Renaissance Technologies (RenTech)'s RNTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 19,000 shares of Rein Therapeutics Inc. (RNTX) worth $19,760, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in RNTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 18,298 shares. Largest reduction occurred in Q2 2024, reducing 20,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Rein Therapeutics (RNTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rein Therapeutics (RNTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -5,500 | Reduce 22.45% | 19,000 | $1.04 |
| Q1 2026 | +1,800 | Add 7.93% | 24,500 | $1.30 |
| Q4 2025 | +4,402 | Add 24.06% | 22,700 | $1.16 |
| Q3 2025 | +18,298 | New Buy | 18,298 | $1.14 |
| Q4 2024 | -13,164 | Sold Out | 0 | $0.00 |
| Q3 2024 | -11,700 | Reduce 47.06% | 13,164 | $3.54 |
| Q2 2024 | -20,200 | Reduce 44.83% | 24,864 | $2.77 |
| Q1 2024 | +17,045 | Add 60.83% | 45,064 | $6.64 |
| Q4 2023 | +9,055 | Add 47.75% | 28,019 | $3.03 |
| Q3 2023 | +3,100 | Add 19.54% | 18,964 | $1.53 |
| Q2 2023 | +3,200 | Add 25.27% | 15,864 | $0.00 |
| Q1 2023 | +2,100 | Add 19.88% | 12,664 | $0.00 |
| Q4 2022 | +10,564 | New Buy | 10,564 | $0.00 |
Renaissance Technologies (RenTech)'s Rein Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Rein Therapeutics Inc. (RNTX) in Q4 2022, acquiring 10,564 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Rein Therapeutics Inc. (RNTX) for 13 quarters since Q4 2022.
Renaissance Technologies (RenTech)'s largest addition to Rein Therapeutics Inc. (RNTX) was in Q3 2025, adding 18,298 shares worth $20,951.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 19,000 shares of Rein Therapeutics Inc. (RNTX), valued at approximately $19,760.
As of the Q2 2026 filing, Rein Therapeutics Inc. (RNTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Rein Therapeutics Inc. (RNTX) was 45,064 shares, as reported at the end of Q1 2024.